Skip to content

Akso Health

US · AHG #3226 by market cap
1.26 -0.02 -1.56%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

After-hours 1.26 0.00%
1.600.691.262026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on AHG?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +2.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 4 of 6 factors. Missing data is not a zero score.

Overall D

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth C

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 1.6% Better than 33%
Net income CAGR (3Y) 16.1% Better than 68%
Free cash flow CAGR (3Y) -48.8% Better than 5%
Profitability D-

How much profit the business keeps from each dollar of sales and capital.

Gross margin -0.1% Better than 2%
Operating margin -28.9% Better than 11%
Net margin -135.0% Better than 6%
Return on equity -9.8% Better than 20%
Return on invested capital -9.8% Better than 18%
Momentum C+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 35.5% Better than 99%
6-month return -17.6% Better than 30%
12-month return (ex latest month) -21.2% Better than 14%
Distance below 52-week high 49.6% Better than 19%
Financial Health A-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 21.8x Better than 98%
Debt to assets 0.2% Better than 98%
Interest coverage -19.8x Better than 10%
Free cash flow / net income 133.3% Better than 59%
Analyst View N/A

What the Street thinks: share of Buy ratings and upside to the average target.

Not enough data to grade this factor.

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W +1.61%
1M +2.69%
3M +23.53%
6M -21.25%
YTD -23.17%
1Y -18.18%
3Y +12.60%
5Y -57.00%

Key statistics

Price & volume

Prev close
1.28
Open
1.30
Day range
1.24 - 1.30
Avg price
1.26
Volume
8.56K
Turnover
10.78K
Amplitude
4.69%
52-week range
0.68 - 2.50

Valuation

P/E
-42.00
P/E (TTM)
-42.00
P/B
5.97
EPS
-0.03
Net profit
-25.70M
Net assets
180.76M

Share structure

Market cap
1.08B
Float cap
1.08B
Shares out
856.70M
Float shares
856.70M

Dividend & listing

Dividend (TTM)
0.00
Listing date
--
52-week range 32% of range
0.68 2.50

49.6% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-60.93K net over the window

Short interest

Shares short
62.36K
As of
2026-10-30

Frequently asked questions

What is the current stock price of Akso Health (AHG)?

Akso Health last traded at 1.26. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Akso Health's market cap?

About 1.08B.

What is the P/E ratio of Akso Health?

The trailing twelve-month P/E is -42.00. The Valuation tab shows it against the stock's own five-year range.

Does Akso Health pay a dividend?

Akso Health does not currently pay a regular dividend.

What is Akso Health's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Akso Health a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Akso Health discussion 0 comments

Add a comment